Prednylidene

Prednylidene

SCHEMBL7568

C=C1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 10/20 0.70
HIF1A Q16665 6/20 0.70
PGR P06401 5/20 0.70
CYP3A4 P08684 4/20 0.70
HSD17B10 Q99714 3/20 0.70
ABCB11 O95342 2/20 0.70
NR3C2 P08235 2/20 0.70
AR P10275 2/20 0.70
TNF P01375 1/20 0.70
IL6 P05231 1/20 0.70
SERPINA6 P08185 1/20 0.70
GLUL P15104 1/20 0.70
ADAM17 P78536 1/20 0.70
GPBAR1 Q8TDU6 1/20 0.70
CYP2C19 P33261 1/20 0.70
LMNA P02545 3/20 0.59
NR1I2 O75469 1/20 0.59
CNR1 P21554 1/20 0.59
ABCC3 O15438 1/20 0.57
ABCC4 O15439 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Prednylidene SCHEMBL19327135 1.00 NR3C1 (0.70) NR3C1HIF1APGRCYP3A4HSD17B10
Prednylidene SCHEMBL1650347 1.00 NR3C1 (0.70) NR3C1HIF1APGRCYP3A4HSD17B10
Prednylidene SCHEMBL3291132 1.00 NR3C1 (0.70) NR3C1HIF1APGRCYP3A4HSD17B10
SCHEMBL11856725 0.92 NR3C1 (0.61) NR3C1HIF1APGRCYP3A4HSD17B10
SCHEMBL11846691 0.92 NR3C1 (0.61) NR3C1HIF1APGRCYP3A4HSD17B10
SCHEMBL11846698 0.92 NR3C1 (0.61) NR3C1HIF1APGRCYP3A4HSD17B10
SCHEMBL11856728 0.92 NR3C1 (0.61) NR3C1HIF1APGRCYP3A4HSD17B10
Prednylidene SCHEMBL28086556 0.90 NR3C1 (0.79) NR3C1HIF1APGRCYP3A4HSD17B10
SCHEMBL11852002 0.89 NR3C1 (0.60) NR3C1HIF1APGRCYP3A4HSD17B10
SCHEMBL11852007 0.89 NR3C1 (0.60) NR3C1HIF1APGRCYP3A4HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 7105 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026100654-A1 NUCLEIC ACID INTRODUCTION AID, NUCLEIC ACID INTRODUCTION AGENT, AND NUCLEIC ACID INTRODUCTION METHOD 株式会社インファーマシア 2026-05-15 WO claimed
EP-3567817-B1 TERMINAL, BASE STATION, AND COMMUNICATION METHOD PANASONIC IP CORP AMERICA (US) 2026-02-18 EP claimed
US-20250255781-A1 PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS BRISTOL-MYERS SQUIBB COMPANY (US) 2025-08-14 US claimed
US-20250205227-A1 METHODS FOR ADMINISTERING CORTICOSTEROIDS SPARROW PHARMACEUTICALS, INC. 2025-06-26 US claimed
WO-2025123147-A1 TOLERIZING IMMUNOMODULATORY COMBINATION INTEGRATED NANOTHERAPEUTICS INC. (CA) 2025-06-19 WO claimed
US-12296043-B2 Liquisoft capsules PATHEON SOFTGELS INC. (US) 2025-05-13 US claimed
US-20250144021-A1 GEL FORMULATIONS FOR LOCAL DRUG RELEASE TECHNICAL UNIVERSITY OF DENMARK (DK) 2025-05-08 US claimed
WO-2025076059-A1 ROCAGLATE DERIVATIVES AND USES THEREOF TRUSTEES OF BOSTON UNIVERSITY (US) 2025-04-10 WO claimed
EP-4218563-B1 ENDOSCOPE SYSTEM AND ENDOSCOPE SYSTEM OPERATION METHOD FUJIFILM CORP (JP) 2025-03-26 EP claimed
EP-3943073-B1 BIODEGRADABLE POLYMER MICROPARTICLE CONTAINING STEROID-BASED DRUG AND PREPARATION METHOD THEREFOR REGENBIOTECH INC (KR) 2025-03-26 EP claimed
EP-0792371-A4 COMBINATION METHOD FOR ACNE TREATMENT MERCK & CO INC (US) 1998-12-30 EP claimed
WO-1998015568-A2 NITRATE ESTERS OF CORTICOID COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF NICOX S.A. (FR) 1998-04-16 WO claimed
WO-1997041144-A1 NOVEL STEROID NITRITE AND NITRATE ESTER DERIVATIVES USEFUL AS ANTI-INFLAMMATORY DRUGS G.D. SEARLE & CO. (US) 1997-11-06 WO claimed
EP-0792371-A1 COMBINATION METHOD FOR ACNE TREATMENT Merck & Co., Inc. (US) 1997-09-03 EP claimed
US-5543417-A 5 Alpha-reductase inhibitor and at least one of an antibacterial agent, a keratolytic agent or an anti-inflammatory agent MERCK & CO., INC. (US) 1996-08-06 US claimed
WO-1996012817-A1 COMBINATION METHOD FOR ACNE TREATMENT MERCK & CO., INC. (US) 1996-05-02 WO claimed
EP-0173478-B1 Treatment of skin disorders SCOTIA HOLDINGS PLC (GB) 1994-02-02 EP claimed
EP-0496520-A1 Novel bone acting agents MERCK & CO. INC. (US) 1992-07-29 EP claimed
US-5095010-A ANTIGESTAGENS, GLUCOCORTICOIDS AND PROSTAGLANDINS FOR INDUCTION OF LABOR OR FOR TERMINATION OF PREGNANCY SCHERING AKTIENGESELLSCHAFT (DE) 1992-03-10 US claimed
EP-0173478-A1 Treatment of skin disorders SCOTIA HOLDINGS PLC (GB) 1986-03-05 EP claimed